Clinical Trial Update: In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells

View source ↗

Summary

This withdrawal notice concerns an in vitro study on depletion of haplotype-mismatched alloreactive T cells in the hematologic malignancies transplant setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Hematologic Malignancies, Hematopoietic Stem Cell Transplantation | Status: WITHDRAWN